Division of Cardiology

Sanjit Jolly

Assistant Professor, Division of Cardiology, Department of Medicine

Education and Professional Standing

Dr. Jolly completed his Bachelor of Science degree at the Queens’ University, Kingston, Ontario. Medical school, internal medicine residency, and cardiology fellowship training were all completed at University of Toronto, Ontario. Subsequently, he has completed an interventional cardiology fellowship at both: St. Michael’s Hospital, University of Toronto and Hamilton Health Sciences, McMaster University. Dr. Jolly is a fellow of the Royal College of Physicians and Surgeons of Canada, with certification in internal medicine and cardiology.

Clinical Interests

Dr. Jolly is a fulltime interventional cardiologist at Hamilton Health Sciences. He is actively involved in postgraduate medical training of residents and fellows in invasive angiography, angioplasty, general cardiology, and internal medicine.

Research Interests

He has formal training in clinical trials with a M.Sc. in Health Research Methodology from McMaster University. His particular research interest is in multicenter randomized clinical trials in acute coronary syndromes and interventional cardiology. He was the principal investigator for the RIVAL trial, an international multicenter trial of 7000 patients comparing radial vs. femoral access for coronary intervention.

Selected Funding

  • TOTAL trial, a randomized trial of routine aspiration thrombectomy vs PCI alone during primary PCI for STEMI, CANNeCTIN, Canadian Network and Centre for Trials internationally
  • TOTAL trial, a randomized trial of routine aspiration thrombectomy vs PCI alone during primary PCI for STEMI, AFP Division of Cardiology, McMaster University
  • RIVAL trial, a randomized trial of radial vs. femoral access for coronary intervention, CANNeCTIN, Canadian Network and Centre for Trials internationally
  • Hamilton Health Sciences, New Investigator Fund Research Grant 2006

Selected Publications

  1. Jolly S, Yusuf S, Phil D, Cairns J, Niemela, K, Xavier D, Widimsky P, Budaj A, Niemela M, Valentin V, Lewis B, Avezum A, Steg P, Rao S, Gao P, Afzal R, Joyner D C, Chrolavicius S, Mehta S. A randomized comparison of RadIal Vs. femorAL (RIVAL) access for coronary angiography and intervention in patients with acute coronary syndromes. Lancet. 2011. 23; 377(9775):1409-20.
  2. Jolly SS, Shenkman H, Brieger D, Fox KA, Yan AT, Eagle KA, Steg PG, Lim KD, Quill A, Goodman SG. Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non ST-segment elevation acute coronary syndromes (NSTE ACS): insight from the Global Registry of Acute Coronary Events. Heart. Feb; Eur Heart J. 97(3):197-202. 2011.
  3. Jolly SS, Niemela K, Xavier D, Widimsky P, Budaj A, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Cairns J, Chrolavicius S, Yusuf S, Mehta SR. Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial; A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes. Am Heart J. 2011;161(@):254-260. 2011.
  4. CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly SS, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med. 2010 Sep 2;363(10):930-42.
  5. Steg PG, Jolly SS, Mehta SR, Afzal R, Xavier D, Rupprecht HJ, Lopez-Sendon JL, Budaj A, Diaz R, Avezum A, Widimsky P, Rao SV, Chrolavicius S, Meeks B, Joyner C, Pogue J, Yusuf S. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. JAMA. Sep 22;304(12):1339-49. 2010.
  6. Jolly S, Pogue Janice, Haladyn K, Peters R, Fox K, Avezum A, Gersh B, Rupprecht H, Yusuf S, Mehta S. Effects of Aspirin dose on Ischemic Events and Bleeding after Percutaneous Coronary Intervention : Insights from the PCI-CURE study. Eur Heart J.2009;30(8):900-7.
  7. Jolly S, Amlani S, Hamon M, Yusuf S, Phil D, Mehta S. Radial versus Femoral Access for Coronary Angiography or Intervention and the Impact on Major Bleeding and Ischemic Events: A Systematic Review and Meta-analysis of Randomized Trials. Am Heart J. 2009;157(1):132-40.
  8. Mehta S, Granger C, Boden W, Steg P, Bassand J, Faxon D, Afzal R, Chrolavicius S, Jolly S, Widimsky P, Avezum A, Rupperecht H, Zhu J, Col J, Natarajan M, Horsman C, Fox K, Yusuf S, TIMACS Investigators. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360(21):2165-75.
  9. Jolly S, Faxon D, Fox K, Rizwan A, Boden W, Widimsky P, Steg G, Valentin V, Budaj A, Granger C, Joyner C, Chrolavicius S, Yusuf S, Mehta S. Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/llla Inhibitors or Thienopyridines. J Am Coll Cardiol. 2009 Jul 28;54(5):468-76.